Skip to content
DataLookout
Menu

NCT06061926

Effect of Celery Seed on the Components of Metabolic Syndrome, Insulin Sensitivity and Insulin Secretion

StatusUnknown
PhasePhase 2
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 3 versions: 2 with changes below, 1 re-verified with no change. See every version on ClinicalTrials.gov ↗

  1. Minor Changed Registry marked status Unknown (sponsor has not verified the record since Oct 2024); last known: Recruiting
  2. Notable Primary endpoints revised (9)
    • Secondary endpoints revised (12)
    • Study description expanded, about 4 words
    v2
  3. Study First Submitted
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

Waist Circumference (WC)
Timeframe: Baseline to week 12 (end of intervention)
Systolic Blood Pressure (SBP)
Timeframe: Baseline to week 12 (end of intervention)
Diastolic Blood Pressure (DBP)
Timeframe: Baseline to week 12 (end of intervention)
High-Density Lipoprotein (HDL-c)
Timeframe: Baseline to week 12 (end of intervention)
Fasting Blood Triglycerides Concentration (TG)
Timeframe: Baseline to week 12 (end of intervention)
Fasting Serum Glucose (FSG)
Timeframe: Baseline to week 12 (end of intervention)
Insulin Sensitivity (Matsuda Index)
Timeframe: Baseline to week 12 (end of intervention)
Total Insulin Secretion
Timeframe: Baseline to week 12 (end of intervention)
First Phase of Insulin Secretion (Stumvoll Index)
Timeframe: Baseline to week 12 (end of intervention)

Secondary (12)

Body weight
Body Mass Index (BMI)
Body Fat Percentage
Total Cholesterol (TC)
Low Density Lipoprotein (LDL-c)
Show 7 moreShow less
Very Low Density Lipoprotein (VLDL)
Concentration of Blood Aspartate Aminostransferase (AST)
Alanine Aminotransferase (ALT)
Creatinine
Uric Acid
Incidence of treatment-Emergent Adverse Events
Tolerability to treatment

Arms and interventions

Celery seedExperimental

14 patients to receive homologated intervention capsule (celery seed 150 mg) one capsule with 75 mg of celery seed, every 12 hours (before breakfast and before dinner) along 12 weeks.

PlaceboPlacebo comparator

14 patients to receive homologated placebo capsule (calcinated magnesia) one capsule with calcinated magnesia, every 12 hours (before breakfast and before dinner) along 12 weeks.

Drugs: Celery Seed, Placebo

Sites

1 site in 1 country

  • INSTITUTO DE TERAPÉUTICA EXPERIMENTAL Y CLÍNICA. Centro Universitario de Ciencias de la SaludGuadalajara, Jalisco, Mexico